Nonclinical drug development is a complex, regulatory-driven process designed primarily to assess the safety and viability of new molecular entities. Nonclinical, or preclinical, services encompass toxicology, pharmacology, metabolism, bioanalysis, pharmaceutical analysis and biosafety testing in support of nonclinical drug development.
　　Nonclinical testing is conducted throughout all phases of drug development and, when done well, can maximize the chances of success in the clinical phases.
　　Proswell offers comprehensive services in all areas of nonclinical drug development. The goal of our nonclinical studies is to determine which compounds have the greatest probability of success, and to build a solid scientific foundation that spans all stages of clinical development.
　　We recognize that you require timely, accurate and accessible data in order to reach critical decisions that affect the progress of your compound. Our commitment is founded on the following tenets:
　●　Leadership — Being a leader means doing things differently from other CROs. We focus on your needs.
　●　Scientific excellence — Our success is founded on the experience of our scientific staff. We're proud of our people.
　●　Favorable price — We provide a much more attractive price to our customer, because we compress the cost constantly.
　●　Regulatory guidance and compliance — Management systems grounded in solid regulatory expertise ensure that our data meet worldwide regulatory compliance.
　●　Service — Our culture is driven by responsiveness. We place the needs of our clients first.